Proteintech Genomics MultiPro Human Discovery Panel
01 November, 2024The MultiPro Human Discovery Pane allowis researchers to explore proteins located both within the intracellular compartments and on the surface of cells.
LSBio PathPlus Cancer Antibodies
07 October, 2024The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer (cancer pathology markers) as well as those that are used in asking a broader series of questions about the aetiology, subclassification and pathogenesis of cancer (cancer molecular markers).
Monoclonal antibody shows protection against COVID variants
17 September, 2024A monoclonal antibody appears effective at neutralising the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to spread in people.
GeneTex G protein-coupled receptor (GPCR) antibodies
06 September, 2024GeneTex's goal is to produce the most extensive line of antibodies for human G protein-coupled receptors (GPCRs).
Proteintech Uni-rAb Recombinant Monoclonal Antibodies
01 September, 2024Uni-rAb antibodies are the latest generation of recombinant monoclonal antibodies developed using Proteintech's Antigen-Specific B-Cell Cloning & Engineering (ABCE) platform.
Leinco Technologies Mouse Anti-Mouse PD-1 Antibody (Clone: 384-35) for cancer immunotherapy research
01 September, 2024When it comes to blocking PD-1/PD-L1 interactions, the Mouse Anti-Mouse PD-1 Antibody (Clone: 384-35), developed by Leinco Technologies, offers high performance across critical research areas.
Bio-Rad Laboratories Pioneer Antibody Discovery Platform SpyLock service
07 August, 2024The SpyLock service enables users to rapidly generate and screen bispecific antibodies to identify effective antibody combinations to take forward into development.
Bio-Rad Laboratories anti-biotherapeutic and anti-MMAE antibodies
10 July, 2024The company's range of ready-made anti-biotherapeutic antibodies enables the development of robust bioanalytical assays against marketed biologic drugs.
HUABIO Nanobodies
03 June, 2024HUABIO Nanobodies are compact antibody fragments derived from heavy-chain-only antibodies. With a size of ~15 kDa, they can penetrate tissues effectively and bind to hidden epitopes with higher binding affinities.
Sino Biological ProVir viral antigen bank
27 May, 2024Sino Biological's viral antigen bank is an extensive repository of recombinant viral antigens, featuring over 1300 antigens spanning 400+ strains.
Antibody levels can predict resolved peanut allergies
17 May, 2024A new study has used antibodies as biomarkers to identify persistent or resolved peanut allergy during the first 10 years of life.
Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers
06 May, 2024The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated antibodies against key immunological targets — are designed to offer researchers high brightness with narrow excitation and emission profiles for precise resolution.
RevMAb Biosciences histone family protein monoclonal antibodies
02 May, 2024RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone family proteins including antibodies against histone modifications such as acetylation, phosphorylation and methylation of different histones.
Biosensis MAP2 antibodies
05 April, 2024Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
02 April, 2024The antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumour heterogeneity and disease progression at various stages.
